Vivos Therapeutics, Inc. Common Stock (VVOS)

$0.61 -2.42%
EARNINGS ANALYTICS
event_upcoming Next Earnings: 2026-08-18 HIGH CONFIDENCE
search

Since May 17, 2021, Vivos Therapeutics, Inc. Common Stock (VVOS) has reported earnings 17 times. On average the shares move ±10.91% post-earnings, with a positive reaction 35.3% of the time. Its largest post-earnings gain was +18.13% (Aug 12, 2021) and its largest decline was -23.65% (Apr 15, 2026). The next earnings report is predicted for 2026-08-18 (high confidence).

Earnings Price Reaction

Scroll to zoom, drag to pan — click earnings dots for details

Beat Miss

Earnings Impact

Total Earnings

17

Avg Abs. Movement

±10.91%

Positive %

35.3%

Negative %

64.7%

Historical Earnings Statistics

Date Timing Open High Close Volume Movement % SEC Filing
Apr 15, 2026 ☽ POST $1.40 $1.52 $1.48 2,607 -23.65% open_in_new
Nov 19, 2025 ☽ POST $2.43 $2.43 $2.36 682 -7.63% open_in_new
Aug 20, 2025 ☽ POST $4.12 $4.20 $4.16 3,328 +3.37% open_in_new
May 15, 2025 ☽ POST $3.12 $3.12 $3.12 337 -19.07% open_in_new
Mar 31, 2025 ☽ POST $2.98 $2.98 $2.93 1,748 -10.58% open_in_new
Nov 14, 2024 ☽ POST $3.12 $3.18 $3.18 1,519 -10.38% open_in_new
Aug 15, 2024 ☽ POST $2.31 $2.31 $2.31 308 +1.3% open_in_new
May 15, 2024 ☽ POST $2.13 $2.19 $2.19 303 +4.57% open_in_new
Aug 16, 2023 ☽ POST $0.33 $0.36 $0.34 2,949 +0% open_in_new
Jun 08, 2023 ☽ POST $0.45 $0.47 $0.47 1,650 -6.67% open_in_new
Mar 30, 2023 ☽ POST $0.34 $0.35 $0.35 1,201 -2.01% open_in_new
Dec 20, 2022 ☽ POST $0.63 $0.63 $0.51 600 -23.32% open_in_new
May 16, 2022 ☽ POST $1.37 $1.37 $1.37 200 +15.33% open_in_new
Mar 31, 2022 ☽ POST $2.70 $2.70 $2.70 200 -17.41% open_in_new
Nov 15, 2021 ☽ POST $3.92 $4.11 $4.08 1,624 -19.73% open_in_new
Aug 12, 2021 ☽ POST $2.80 $2.88 $2.79 2,531 +18.13% open_in_new
May 17, 2021 ☽ POST $6.01 $6.03 $6.01 1,042 -2.24% open_in_new
event

Earnings Count

17

Total earnings in dataset

trending_up

Avg Abs. Movement

±10.91%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

SEC Filing Types

Recent SEC Filings

6 most recent
Form Date Filed View on EDGAR
8-K 20260608 open_in_new SEC.gov
10-Q 20260520 open_in_new SEC.gov
NT 10-Q 20260515 open_in_new SEC.gov
SCHEDULE 13G 20260515 open_in_new SEC.gov
CORRESP 20260506 open_in_new SEC.gov
UPLOAD 20260223 open_in_new SEC.gov

Frequently asked about VVOS earnings

When does Vivos Therapeutics, Inc. Common Stock report earnings next? expand_more

Vivos Therapeutics, Inc. Common Stock (VVOS)'s next earnings date is predicted (high confidence) for 2026-08-18. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does VVOS stock move after earnings? expand_more

Over 17 reports, VVOS has moved an average of ±10.91% the session after earnings, closing higher 35.3% of the time.

What was VVOS's biggest post-earnings move? expand_more

VVOS's largest post-earnings gain on record was +18.13% on Aug 12, 2021, and its largest decline was -23.65% on Apr 15, 2026.

Where can I find Vivos Therapeutics, Inc. Common Stock's SEC filings? expand_more

All of Vivos Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.

Sector peers